University of Miami’s Stem Cell Institute Awarded $10 Million
June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States. The grant will support ISCI in broadening its pre-clinical and clinical research on stem cells, and help accelerate its pipeline of translational research and programs for a wide range of debilitating conditions including cardiac disease, cancer, wound healing, stroke, glaucoma, and chronic kidney and gastrointestinal diseases.
The Starr Foundation has long been involved in stem cell research and its potential to dramatically change the way physicians treat and cure disease. Similarly, ISCI was founded in 2008 with the goal to discover and advance cell-based therapies for devastating and untreatable diseases and help unlock the power of regenerative medicine.
ISCI is currently leading 13 clinical trials evaluating the use of stem cells in patients with conditions including congestive heart failure, skin wounds, burns, pulmonary fibrosis and stroke.
For more information: www.med.miami.edu
More like this
- CellCyte, Cleveland Clinic Qualify Stem Cell Delivery in Damaged Hearts
- Heart Damage Improves, Reverses After Stem Cell Injections in a Preliminary Human Trial
- AHA Funds Three Research Centers to Study Generation of Cardiac Muscle Cells
- International Conference on Cell Therapy for Cardiovascular Disease Set for Jan. 13-16
- CRF to Hold CVD Cell Therapy Conference